Íõع½Ü
?
Ò»¡¢¸öÈ˼ò½é
Íõع½Ü£¬²©Ê¿£¬¸±Ñо¿Ô±£¬Ë¶Ê¿Ñо¿Éúµ¼Ê¦£¬Ãñ×åҽҩѧԺ½Ìʦ¡£Ñо¿·½ÏòΪÖÐÒ©¡¢Ãñ×åҩҩЧÎïÖÊ»ù´¡¼°ÅÚÖÆÔÀíÑо¿¡£ÏȺó³Ðµ£¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¡¢½ÌÓý²¿²©Ê¿µã»ù½ð¡¢Öйú²©Ê¿ºó»ù½ð¡¢ËÄ´¨Ê¡¿Æ¼¼¼Æ»®µÈ¿ÆÑÐÏîÄ¿£»ÒÔµÚÒ»×÷Õß»òͨѶ×÷Õß·¢±íѧÊõÂÛÎÄ30Óàƪ£»²Î±à¡¶ËÄ´¨Ê¡²ØÒ©²Ä±ê×¼¡·µÈרÖø£»Ïà¹ØÑо¿³É¹û»ñËÄ´¨Ê¡¿Æ¼¼½ø²½¶þµÈ½±1ÏÃñ×åÒ½Ò©¿Æѧ¼¼Êõ½ø²½Ò»µÈ½±1Ïî¡£
¶þ¡¢´ú±íÐԳɹû
ÂÛÎÄ
(1) Yan Wang, Pei Tao, Yujie Wang*. Attenuated structural transformation of indaconitine during sand frying process and anti-arrhythmic effects of its transformed products. Evidence-Based Complementary and Alternative Medicine. 2022: 8606459.
(2) Pei Tao, Yan Wang, Yujie Wang*. Attenuation and structural transformation of crassicauline A during sand frying process and antiarrhythmic effects of its transformed products. Frontiers in Pharmacology 2021, 12:734671.
(3) Yujie Wang*, Yan Wang, Pei Tao. Attenuated structural transformation of aconitine during sand frying process and antiarrhythmic effect of its converted products. Evidence-Based Complementary and Alternative Medicine. 2021: 7243052.
(4) ÌÕÅà, Íõع½Ü*. ¸ßÎÚ¼×Ëؼ°ÆäË®½â²úÎï´ÌÎÚÄþ¿¹ÐÄÂÉʧ³£×÷ÓõıȽÏÑо¿. ÖвÝÒ©, 2021, 52(23): 7214-7220.
(5) ÍõÑÞ, ÌÕÅà, Íõع½Ü*, µËά¼Ñ. ÓÍÔ¡Ä£ÄâÉ°³´¹ý³ÌÖÐÓ¡ÎÚ¼îµÄ½á¹¹×ª»¯Í¾¾¶¼°×ª»¯²úÎﶾÐÔÑо¿. ÖвÝÒ©. 2020, 51(5): 1205-1213.
»ñ½±
(1) Íõع½Ü£¨4/8£©£¬ÌØÉ«²ØÒ©Æ·ÖÊÕûºÏÆÀ¼Û¹Ø¼ü¼¼ÊõµÄ´´½¨Óë²úÒµ»¯Ó¦Óã¬ËÄ´¨Ê¡ÈËÃñÕþ¸®£¬ËÄ´¨Ê¡¿Æ¼¼½ø²½½±£¬¶þµÈ½±£¬2019Äê
(2) Íõع½Ü£¨6/15£©£¬²ØÒ©ºì¾°Ìì¼°Ïà¹ØÖƼÁ·ÀÖÎȱÑõÐÔÐÄÄÔѪ¹Ü¼²²¡µÄÑо¿£¬ÖйúÃñ×åҽҩѧ»á£¬Ãñ×åÒ½Ò©¿Æѧ¼¼Êõ½ø²½½±£¬Ò»µÈ½±£¬2017Äê